Sonowal, Himangshu

Aldose reductase inhibitor increases doxorubicin-sensitivity of colon cancer cells and decreases cardiotoxicity. [electronic resource] - Scientific reports 06 2017 - 3182 p. digital

Publication Type: Journal Article; Research Support, N.I.H., Extramural

2045-2322

10.1038/s41598-017-03284-w doi


ATP Binding Cassette Transporter, Subfamily B, Member 1--genetics
ATP Binding Cassette Transporter, Subfamily G, Member 2--genetics
Aldehyde Reductase--antagonists & inhibitors
Animals
Cardiotoxicity--drug therapy
Cell Proliferation
Colonic Neoplasms--drug therapy
Doxorubicin--administration & dosage
Drug Resistance, Neoplasm--genetics
Gene Expression Regulation, Neoplastic--drug effects
HT29 Cells
Humans
Imidazolidines--administration & dosage
Mice
Multidrug Resistance-Associated Proteins--genetics
Neoplasm Proteins--genetics
Xenograft Model Antitumor Assays